Ann C. Miller - May 15, 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Ann C. Miller
Stock symbol
INO
Transactions as of
May 15, 2023
Transactions value $
$0
Form type
4
Date filed
5/16/2023, 04:50 PM
Previous filing
May 17, 2022
Next filing
May 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +19K +39.97% 66.5K May 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -19K -100% $0.00* 0 May 16, 2023 Common Stock 19K Direct F1
transaction INO Common Stock Options Award $0 +35K $0.00 35K May 15, 2023 Common Stock 35K $0.77 Direct F2, F3
transaction INO Restricted Stock Unit Award $0 +26K $0.00 26K May 15, 2023 Common Stock 26K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.
F2 This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.
F3 Options to vest 100% on May 15, 2024.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024.